Your browser doesn't support javascript.
loading
Autoimmunity plays a role in the onset of diabetes after 40 years of age.
Rolandsson, Olov; Hampe, Christiane S; Sharp, Stephen J; Ardanaz, Eva; Boeing, Heiner; Fagherazzi, Guy; Mancini, Francesca Romana; Nilsson, Peter M; Overvad, Kim; Chirlaque, Maria-Dolores; Dorronsoro, Miren; Gunter, Marc J; Kaaks, Rudolf; Key, Timothy J; Khaw, Kay-Tee; Krogh, Vittorio; Kühn, Tilman; Palli, Domenico; Panico, Salvatore; Sacerdote, Carlotta; Sánchez, Maria-José; Severi, Gianluca; Spijkerman, Annemieke M W; Tumino, Rosario; van der Schouw, Yvonne T; Riboli, Elio; Forouhi, Nita G; Langenberg, Claudia; Wareham, Nicholas J.
Afiliación
  • Rolandsson O; Department of Public Health and Clinical Medicine, Family Medicine, Umeå University, 901 87, Umeå, Sweden. olov.rolandsson@umu.se.
  • Hampe CS; Department of Medicine, Division of Metabolism, Endocrinology and Nutrition, University of Washington, Seattle, WA, USA.
  • Sharp SJ; MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.
  • Ardanaz E; Navarre Public Health Institute, Pamplona, Spain.
  • Boeing H; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Publica), Madrid, Spain.
  • Fagherazzi G; IdiSNA, Navarra Institute for Health Research, Pamplona, Spain.
  • Mancini FR; Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.
  • Nilsson PM; CESP, Faculty of Medicine - University Paris-South, Faculty of Medicine Inserm U1018, University Paris-Saclay, Villejuif, France.
  • Overvad K; CESP, Faculty of Medicine - University Paris-South, Faculty of Medicine Inserm U1018, University Paris-Saclay, Villejuif, France.
  • Chirlaque MD; Department of Clinical Sciences, Clinical Research Center, Skåne University Hospital, Lund University, Malmö, Sweden.
  • Dorronsoro M; Department of Public Health, Aarhus University, Aarhus, Denmark.
  • Gunter MJ; Department of Cardiology, Aalborg University Hospital, Aalborg, Denmark.
  • Kaaks R; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Publica), Madrid, Spain.
  • Key TJ; Department of Epidemiology, Murcia Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
  • Khaw KT; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Publica), Madrid, Spain.
  • Krogh V; Public Health Division of Gipuzkoa, Basque Government, San Sebastian, Spain.
  • Kühn T; Instituto BIO-Donostia, Basque Government, San Sebastian, Spain.
  • Palli D; International Agency for Research on Cancer, Lyon, France.
  • Panico S; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Sacerdote C; Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, UK.
  • Sánchez MJ; Department of Public Health and Primary Care, University of Cambridge, Addenbrooke's Hospital, Cambridge, UK.
  • Severi G; Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy.
  • Spijkerman AMW; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Tumino R; Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.
  • van der Schouw YT; Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.
  • Riboli E; Unit of Cancer Epidemiology, Azienda Ospedaliera Universitaria (AOU) Citta' della Salute e della Scienza Hospital-University of Turin and Center for Cancer Prevention (CPO), Torino, Italy.
  • Forouhi NG; Consortium for Biomedical Research in Epidemiology and Public Health (CIBER Epidemiología y Salud Publica), Madrid, Spain.
  • Langenberg C; Andalusian School of Public Health, Granada, Spain.
  • Wareham NJ; Instituto de Investigación Biosanitaria de Granada (ibs.GRANADA), Universidad de Granada, Granada, Spain.
Diabetologia ; 63(2): 266-277, 2020 02.
Article en En | MEDLINE | ID: mdl-31713011
ABSTRACT
AIMS/

HYPOTHESIS:

Type 1 and type 2 diabetes differ with respect to pathophysiological factors such as beta cell function, insulin resistance and phenotypic appearance, but there may be overlap between the two forms of diabetes. However, there are relatively few prospective studies that have characterised the relationship between autoimmunity and incident diabetes. We investigated associations of antibodies against the 65 kDa isoform of GAD (GAD65) with type 1 diabetes and type 2 diabetes genetic risk scores and incident diabetes in adults in European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct, a case-cohort study nested in the EPIC cohort.

METHODS:

GAD65 antibodies were analysed in EPIC participants (over 40 years of age and free of known diabetes at baseline) by radioligand binding assay in a random subcohort (n = 15,802) and in incident diabetes cases (n = 11,981). Type 1 diabetes and type 2 diabetes genetic risk scores were calculated. Associations between GAD65 antibodies and incident diabetes were estimated using Prentice-weighted Cox regression.

RESULTS:

GAD65 antibody positivity at baseline was associated with development of diabetes during a median follow-up time of 10.9 years (HR for GAD65 antibody positive vs negative 1.78; 95% CI 1.43, 2.20) after adjustment for sex, centre, physical activity, smoking status and education. The genetic risk score for type 1 diabetes but not type 2 diabetes was associated with GAD65 antibody positivity in both the subcohort (OR per SD genetic risk 1.24; 95% CI 1.03, 1.50) and incident cases (OR 1.97; 95% CI 1.72, 2.26) after adjusting for age and sex. The risk of incident diabetes in those in the top tertile of the type 1 diabetes genetic risk score who were also GAD65 antibody positive was 3.23 (95% CI 2.10, 4.97) compared with all other individuals, suggesting that 1.8% of incident diabetes in adults was attributable to this combination of risk factors. CONCLUSIONS/

INTERPRETATION:

Our study indicates that incident diabetes in adults has an element of autoimmune aetiology. Thus, there might be a reason to re-evaluate the present subclassification of diabetes in adulthood.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoinmunidad / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Año: 2020 Tipo del documento: Article País de afiliación: Suecia

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Autoinmunidad / Diabetes Mellitus Tipo 1 / Diabetes Mellitus Tipo 2 Tipo de estudio: Observational_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Diabetologia Año: 2020 Tipo del documento: Article País de afiliación: Suecia
...